Rimegepant for vestibular and cochlear symptoms associated with vertigo in a real-world retrospective study. [PDF]
Zhai Z +15 more
europepmc +1 more source
Comparative efficacy of AAC and ibuprofen versus lasmiditan, ubrogepant, and rimegepant for the acute treatment of episodic migraine in adults: a systematic review and network meta-analysis. [PDF]
Mitra A +4 more
europepmc +1 more source
Efficacy and safety of gepants in migraine management: a narrative review focusing on atogepant and rimegepant. [PDF]
Gautier A +3 more
europepmc +1 more source
Mengyi Li, Siyong Huang, Jiabao Li, Xiao Hu, Jisheng Chen Key Specialty of Clinical Pharmacy, the First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, People’s Republic of ChinaCorrespondence: Jisheng Chen, Key Specialty of ...
Li M, Huang S, Li J, Hu X, Chen J
doaj
Hair loss in the era of CGRP inhibition: emerging evidence, mechanisms, and clinical implications. [PDF]
Antanaitytė A +3 more
europepmc +1 more source
Efficacy, tolerability and barriers to the use of anti-CGRP medications among migraine patients in Egypt: real world experience. [PDF]
Gomaa MA +4 more
europepmc +1 more source
Rimegepant in the Treatment of Migraine Headache: The Importance of Comparator Treatments [PDF]
Christine Ju +3 more
openaire +1 more source
Does rimegepant prevent migraine attacks in people who have not found other treatments taken by mouth (orally) to work well? A plain language summary of clinical study findings. [PDF]
Pozo-Rosich P +9 more
europepmc +1 more source
Can rimegepant stop symptoms of a migraine attack in people who have not found triptans to work well or are not recommended to use triptans? A plain language summary of a clinical study. [PDF]
Ashina M +9 more
europepmc +1 more source

